PREDICTIVE RESPONSE MARKERS FOR IMMUNE RESPONSE BLOCKS

PREDICTIVE RESPONSE MARKERS FOR IMMUNE RESPONSE BLOCKS

Despite the unprecedented success in using immune checkpoint inhibitors in the treatment of lung cancer, melanoma, hypermutable tumors of various localization, etc., a significant proportion of patients receiving these drugs do not respond to treatment. Predictive markers routinely used in the selec...

Full description

Bibliographic Details
Main Authors: G. A. Janus, A. G. Ievleva, E. N. Suspitsyn, V. I. Tyurin, I. V. Bizin, O. A. Gorustovich, V. I. Ni, M. M. Kholmatov, T. A. Laidus, S. A. Chuynyshena, S. N. Aleksakhina, E. N. Imyanitov
Format: Article
Language:Russian
Published: Tomsk National Research Medical Center of the Russian Academy of Sciences 2020-09-01
Series:Sibirskij Onkologičeskij Žurnal
Subjects:
adenocarcinoma
predictive markers
immune response checkpoint inhibitors
pd-l1
pd1
ctla4
Online Access:https://www.siboncoj.ru/jour/article/view/1538

Internet

https://www.siboncoj.ru/jour/article/view/1538

Similar Items